News Search Results
Feb 07, 2025, 05:10 ET Wound Closure Strips Market to Grow by USD 102.8 Million from 2025-2029, Driven by Focus on Reducing SSIs, Report with Market Evolution Powered by AI - Technavio
and traditional surface stitches, as well as alternatives to staples and sutures. The market is expected to grow further due to advancements in biotechnology industries and the need for effective wound closure solutions in trauma centers.
More news about: Technavio
Feb 07, 2025, 04:04 ET Nano Positioning Systems Market to Grow by USD 183.95 Million (2024-2028), Driven by Nanotechnology & Market Evolution Powered by AI - Technavio
application scope in sectors such as semiconductor manufacturing, photonics packaging, and biotechnology. Optical scanning, alignment, and imaging applications are significant areas of growth. Nanotechnology and biotechnology are key markets, with applications in areas such as quantum computing, nanoscale electronics,
More news about: Technavio
Feb 06, 2025, 20:31 ET GCCL Wins 2025 Asia-Pacific Customer Value Leadership Award by Frost & Sullivan
analytical platforms including ddPCR technology, and its specialized expertise in sample analysis and method development. Serving pharmaceutical and biotechnology companies as well as in Korea, Asia, and beyond, GCCL is committed to deliver world-class, customized clinical
More news about: GCCL
Feb 06, 2025, 10:30 ET Temperature Monitoring Systems Market to Hit USD 5.66 Billion by 2030 with 5.3% CAGR | MarketsandMarkets™
markets in developing countries are characterized by the presence of stringent regulatory policies for food and drug safety. Also, growth of the biotechnology and pharmaceutical industries in the Asia Pacific are considered to be more adaptive and business-friendly by market
More news about: MarketsandMarkets
Feb 06, 2025, 09:00 ET K18 EXPANDS REACH WITH LAUNCH AT COSMO PROF, FURTHER EMPOWERING PROFESSIONAL STYLISTS
marks the brand's continued expansion to support professional stylists, with its high-performance products, accessible education, and revolutionary biotechnology now available through Cosmo Prof's expansive network as the largest distributor of professional branded beauty products to the salon community in
More news about: K18 Biomimetic Hairscience
Feb 06, 2025, 08:39 ET Crown Laboratories Announces Completion of Acquisition of Revance Therapeutics
in the skincare industry, today announced the successful closing of its acquisition of Revance Therapeutics, Inc. ("Revance") (NASDAQ: RVNC), a biotechnology company aimed at setting the new standard in healthcare with innovative aesthetic and therapeutic offerings.
More news about: Crown Laboratories, Inc.
Feb 06, 2025, 08:34 ET Gulf Energy Information and DECHEMA Partner to Launch ChemE Show--Powered by ACHEMA in 2026
Biotechnologie e.V. (Society for Chemical Engineering and Biotechnology) brings together experts from a wide range of disciplines, institutions and generations to stimulate scientific exchange in chemical engineering, process engineering and biotechnology. We identify and evaluate emerging technological trends
More news about: Gulf Energy Information
Feb 06, 2025, 08:08 ET COEPTIS Completes $10 Million Series A Preferred Financing Round, Reinforcing Commitment to Technological Innovation and AI Integration
"Coeptis"), a pioneering technology company dedicated to advancing cutting-edge technologies and artificial intelligence at the forefront of innovative biotechnology therapeutic solutions, today announced the successful closure of an additional $5.7 million in its final Series A
More news about: Coeptis Pharmaceuticals, Inc.
Feb 06, 2025, 08:01 ET Ginkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference Series
here. Connect with fellow innovators and leaders, and develop the relationships and ideas that will shape the future of biotechnology. For more information about Ginkgo's 2025 Ferment series and to subscribe to updates, please visit our
More news about: Ginkgo Bioworks
Feb 06, 2025, 07:30 ET Palatin Completes Phase 2 Obesity Study With MC4R Bremelanotide Plus GLP-1/GIP Tirzepatide
complete clinical trials and submit applications for regulatory approvals, products developed by competing pharmaceutical, biopharmaceutical and biotechnology companies, commercial acceptance of Palatin's products, and other factors discussed in Palatin's periodic filings with the Securities and Exchange
More news about: Palatin Technologies, Inc.
Feb 06, 2025, 07:00 ET Nanoscope Therapeutics to Present at the BIO CEO and Investor Conference
Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real-world settings by developing and commercializing novel gene therapies for retinal
More news about: Nanoscope Therapeutics
Feb 06, 2025, 06:45 ET Lilly reports full Q4 2024 financial results and provides 2025 guidance
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Feb 05, 2025, 17:03 ET New England Journal of Medicine Publishes Results of Global, Multicenter eNRGy Study Evaluating Zenocutuzumab-zbco (BIZENGRI®) in NRG1+ cancer
Feb. 5, 2025 /PRNewswire/ -- Partner Therapeutics, Inc. (PTx), a private, fully-integrated biotechnology company announced today that the
More news about: Partner Therapeutics, Inc.
Feb 05, 2025, 16:30 ET Corteva Strong 4Q Driven by Record Crop Demand, Disciplined Execution
commercialize Corteva's pipeline; (iii) effect of the degree of public understanding and acceptance or perceived public acceptance of Corteva's biotechnology and other agricultural products; (iv) effect of changes in agricultural and related policies of governments and international organizations; (v)
More news about: Corteva Agriscience
Feb 05, 2025, 14:35 ET Tidal Vision completes $140M Series B to Scale Chitosan Technologies Globally
BELLINGHAM, Wash., Feb. 5, 2025 /PRNewswire/ -- Tidal Vision, a biotechnology company transforming critical industries with chitosan-based chemistries, announced the closing of an oversubscribed $140M
More news about: Tidal Vision
Feb 05, 2025, 13:30 ET GCCL Applauded by Frost & Sullivan for Ensuring Consistent, Reliable Clinical Trial Data in APAC
Customer Value Leadership Award. The company has rapidly established itself as a key player in central lab services, supporting the pharmaceutical and biotechnology industries with robust expertise and commitment to quality. Specializing in multinational clinical trials across APAC, GCCL provides comprehensive
More news about: Frost & Sullivan
Feb 05, 2025, 13:30 ET GCCL Applauded by Frost & Sullivan for Ensuring Consistent, Reliable Clinical Trial Data in APAC
Customer Value Leadership Award. The company has rapidly established itself as a key player in central lab services, supporting the pharmaceutical and biotechnology industries with robust expertise and commitment to quality. Specializing in multinational clinical trials across APAC, GCCL provides comprehensive
More news about: Frost & Sullivan
Feb 05, 2025, 12:00 ET TCBP to Implement ADS Ratio Change
Feb. 5, 2025 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced that it will change its ratio
More news about: TC BioPharm
Feb 05, 2025, 12:00 ET The Vilcek Foundation Honors Dr. Henry Louis Gates Jr. with $100,000 Award
administration of justice (Robert Katzmann), in public service (Andrew Yang), and in biotechnology (Katalin Karikó). Unlike the Vilcek Prizes in Biomedical Science and in the Arts and Humanities, which specifically recognize immigrant professionals,
More news about: The Vilcek Foundation
Feb 05, 2025, 10:30 ET Peptide Synthesis Market to Hit USD 1.41 Billion by 2029 with 11.7% CAGR | MarketsandMarkets™.
synthesis market is segmented by end users into pharmaceutical and biotechnology companies, CDMOS & CROS, academic and research institutes, medical device companies, and hospitals and diagnostic centers. The pharmaceutical and biotechnology companies segment held the largest market share in 2023. The rise
More news about: MarketsandMarkets
Feb 05, 2025, 09:18 ET Actinogen announces new and unique nonproprietary name of 'emestedastat' for Xanamem
effectively blocking generic competition for that period. About Actinogen Medical Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel therapy for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol. There is a strong
More news about: Actinogen Medical Limited
Feb 05, 2025, 09:00 ET BioMarin to Host Fourth Quarter and Full-Year 2024 Financial Results Conference Call and Webcast on Wednesday, February 19, 2025, at 4:30pm ET
https://investors.biomarin.com/. A replay of the call will be archived on the site for one week following the call. About BioMarinBioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The
More news about: BioMarin Pharmaceutical Inc.
Feb 05, 2025, 08:00 ET Dovetail Genomics Announces HudsonAlpha as First North American Certified Service Provider
HudsonAlpha Institute for Biotechnology Genome Sequencing Center as the first North American member of the Dovetail® Certified Service Provider program. This certification
More news about: Dovetail Genomics
Feb 05, 2025, 08:00 ET Crown Laboratories and Revance Therapeutics Announce Expiration of Tender Offer
registered trademarks of Bellus Medical, LLC and StriVectin Operating Company, Inc., respectively. About Revance Revance is a biotechnology company setting the new standard in healthcare with innovative aesthetic and therapeutic offerings that enhance patient outcomes and physician experiences.
More news about: Crown Laboratories, Inc.
Feb 05, 2025, 07:00 ET Marengo Therapeutics Announces the Appointment of Elena Garralda, MD, PhD, to its Scientific Advisory Board
Mass., Feb. 5, 2025 /PRNewswire/ -- Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel approaches for precision immunotherapy in Oncology, today announced the appointment of Elena Garralda,
More news about: Marengo Therapeutics